Histological study of stem-like cells in human colon adenocarcinoma at different stages of the disease

References

• Ahmed MA, Al-Attar A, Kim J, Watson NF, Scholefield JH, Durrant LG, Ilyas M (2009) CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer. J. Clin. Pathol. 62: 1117–1122.
   PubMed Web of Science ®Google Scholar
• Al-Hajj M, Wicha MS, Ito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100: 3983–3988.
   PubMed Web of Science ®Google Scholar
• Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3: 730–737.
   PubMed Web of Science ®Google Scholar
• Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T (2005) Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5: 744–749.
   PubMed Web of Science ®Google Scholar
• Camp RL, Charette LA, Rimm DL (2000) Validation of tissue microarray technology in breast carcinoma. Lab. Invest. 80: 1943–1949.
   PubMed Web of Science ®Google Scholar
• Choi D, Lee HW, Hur KY, Kim JJ, Park GS, Jang SH, Song YS, Jang KS, Paik SS (2009) Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J. Gastroenterol. 15: 2258–2264.
   Google Scholar
• Derwinger K, Kodeda K, Bexe-Lindskog E, Taflin H (2010) Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer. Acta Oncol. 49: 57–62.
   PubMed Web of Science ®Google Scholar
• Du L, Wang H, He L, Zhang J, Ni B, Wang X, Jin H, Cahuzac N, Mehrpour M, Lu Y, Chen Q (2008) CD44 is of functional importance for colorectal cancer stem cells. Clin. Cancer Res.14: 6751–6760.
   PubMed Web of Science ®Google Scholar
• Edge SB, Byrd DR, Compton CC (2010) Colon and Rectum in AJCC Cancer Staging Manual, 7th ed. Springer, New York. pp. 143–64.
   Google Scholar
• Giatromanolaki A, Sivridis E, Fiska A, Koukourakis MI (2010) The CD44+/CD24- phenotype relates to ‘triple-negative’ state and unfavorable prognosis in breast cancer patients. Med. Oncol. Apr 20. (E-pub ahead of print).
   Google Scholar
• Hollier BG, Evans K, Mani SA (2009) The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J. Mam. Gland Biol. Neoplasia 14: 29–43.
   PubMed Web of Science ®Google Scholar
• Horst D, Kriegl L, Engel J, Kirchner T, Jung A (2008) CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br. J. Cancer 99: 1285–1289.
   PubMed Web of Science ®Google Scholar
• Horst D, Kriegl L, Engel J, Kirchner T, Jung A (2009a) Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer. Cancer Invest. 27: 844–850.
   PubMed Web of Science ®Google Scholar
• Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, Kirchner T, Jung A (2009b) The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J. Pathol. 219: 427–434.
   PubMed Web of Science ®Google Scholar
• Hsu SM, Raine L, Fanger H (1981) Use of avidin- biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577–580.
   PubMed Web of Science ®Google Scholar
• Huang EH, Wicha MS (2008) Colon cancer stem cells: implications for prevention and therapy. Trends Mol. Med. 14: 503–509.
   PubMed Web of Science ®Google Scholar
• Karbanova J, Missol-Kolka E, Fonseca AV, Lorra C, Janich P, Hollerová H, Jászai J, Ehrmann J, Kolár Z, Liebers C, Arl S, Subrtová D, Freund D, Mokry J, Huttner WB, Corbeil D (2008) The stem cell marker CD133 pProminin-1) is expressed in various human glandular epithelia. J. Histochem. Cytochem. 56: 977–993.
   PubMed Web of Science ®Google Scholar
• Li F, Tiede B, Massague J, Kang Y (2007) Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res. 17: 3–14.
   PubMed Web of Science ®Google Scholar
• Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC, Wong H, Rosen J, Chang JC (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl. Cancer Inst. 100: 672–679.
   PubMed Web of Science ®Google Scholar
• Li CY, Li BX, Liang Y, Peng RQ, Ding Y, Xu DZ, Zhang X, Pan ZZ, Wan DS, Zeng YX, Zhu XF, Zhang XS (2009) Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J. Transl. Med. 7: 56.
   PubMedGoogle Scholar
• Lim SC, Oh SH (2005) The role of CD24 in various human epithelial neoplasias. Pathol. Res. Pract. 201: 479–486.
   PubMed Web of Science ®Google Scholar
• Maeda S, Shinchi H, Kurahara H, Mataki Y, Maemura K, Sato M, Natsugoe S, Aikou T, Takao S ( 2008) CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br. J. Cancer 98: 1389–1397.
   PubMed Web of Science ®Google Scholar
• McCarty KS Jr, Szabo E, Flowers JL, Cox EB, Leight GS, Miller L, Konrath J, Soper JT, Budwit DA, Creasman WT, Seigier H F, McCarty KS (1986) Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res. 46: 4244s–4248s.
   PubMed Web of Science ®Google Scholar
• O’Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106–110.
   PubMed Web of Science ®Google Scholar
• Puglisi MA, Sgambato A, Saulnier N, Rafanelli F, Barba M, Boninsegna A, Piscaglia AC, Lauritano C, Novi ML, Barbaro F, Rinninella E, Campanale C, Giuliante F, Nuzzo G, Alfieri S, Doglietto GB, Cittadini A, Gasbarrini A (2009) Isolation and characterization of CD133+ cell population within human primary and metastatic colon cancer. Eur. Rev. Med. Pharmacol. Sci. 13: 55–62.
   Google Scholar
• Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111–115.
   PubMed Web of Science ®Google Scholar
• Rojo MG, Bueno G, Slodkowska J (2009) Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice. Folia Histochem. Cytobiol. 47: 349–354.
   PubMed Web of Science ®Google Scholar
• Saif MW, Chu E (2010) Biology of colorectal cancer. Cancer J. 16: 196–201.
   PubMed Web of Science ®Google Scholar
• Sajithlal GB, Rothermund K, Zhang F, Dabbs DJ, Latimer JJ, Grant SG, Prochownik EV (2010) Permanently blocked stem cells derived from breast cancer cell lines. Stem Cells 28: 1008–1018.
   Google Scholar
• Scheele J, Stang R, Tendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J. Surg. 19: 59–71.
   PubMed Web of Science ®Google Scholar
• Shackleton M, Quintana E, Fearon ER, Morrison SJ (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138: 822–829.
   PubMed Web of Science ®Google Scholar
• Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T St,. Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, D’Angelica M, Kemeny N, Lyden D, Rafii S (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J. Clin. Invest. 118: 2111–2120.
   PubMed Web of Science ®Google Scholar
• Thalheimer A, Otto C, Bueter M, Illert B, Gattenlohner S, Gasser M, Fein M, Germer CT, Waaga-Gasser AM (2009) Tumor cell dissemination in a human colon cancer animal model: orthotopic implantation or intraportal injection?Eur. Surg. Res. 42: 195–200.
   Google Scholar
• Todaro M, Francipane MG, Medema JP, Stassi G (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138: 2151–2162.
   PubMed Web of Science ®Google Scholar
• Tsutsumi S, Kuwano H, Morinaga N, Shimura T, Asao T (2001) Animal model of para-aortic lymph node metastasis. Cancer Lett. 169: 77–85.
   Google Scholar
• Yoshikawa S, Zen Y, Fujii T, Sato Y, Ohta T, Aoyagi Y, Nakanuma Y (2009) Characterization of CD133+ parenchymal cells in the liver: histology and culture. World J. Gastroenterol. 15: 4896–4906.
   Google Scholar